Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Janssen-Cilag Pty Ltd
Scientific Title
A Phase 3 Randomized, Multicenter Study of Subcutaneous vs. Intravenous Administration of Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma